Keyphrases
Aberrant DNA Methylation
100%
Adenocarcinoma Cells
20%
Aggressive Therapy
20%
Cancer Causes
20%
Cancer Mortality
20%
Cancer Subgroups
20%
Confidence Interval
20%
Cox Proportional Hazards Model
20%
Disease Outcome
20%
DNA Methylation (DNAm)
20%
DNA Methylation Pattern
20%
Genome Scan
20%
Hazard Ratio
20%
Lung Cancer
40%
Multivariate Analysis
40%
N Stage
20%
Non-small Cell Lung Cancer (NSCLC)
100%
Non-small Cell Lung Cancer Patients
80%
Oligodendrocyte
100%
Overall Survival
20%
Overall Survival of Patients
20%
Patient Samples
20%
Postoperative Adjuvant Chemotherapy
20%
Prognostic Factors
100%
Protein Expression
60%
Relative Risk
20%
Resectable Tumors
20%
Squamous Cell Carcinoma (SqCC)
20%
T Stage
20%
T2N0
20%
Transcription Factor
100%
Tumor-node-metastasis
20%
Tumor-node-metastasis Staging
20%
Univariate Analysis
20%
Medicine and Dentistry
Adenocarcinoma
16%
Adjuvant Chemotherapy
16%
Diseases
16%
DNA Methylation
100%
Fibrinogen
100%
Hazard Ratio
16%
Lung Cancer
33%
Malignant Neoplasm
16%
Metastatic Carcinoma
33%
Multivariate Analysis
33%
Neoplasm
50%
Non Small Cell Lung Cancer
100%
Oligodendrocyte
100%
Overall Survival
33%
Prognostic Factor
100%
Proportional Hazards Model
16%
Protein Expression
50%
Restriction Landmark Genomic Scanning
16%
Squamous Cell Carcinoma
16%
Transcription Factors
100%
Univariate Analysis
16%
Biochemistry, Genetics and Molecular Biology
DNA Methylation
100%
Fibrinogen
100%
Multivariate Analysis
40%
Oligodendrocyte
100%
Overall Survival
40%
Protein Expression
60%
Restriction Landmark Genomic Scanning
20%
Transcription Factors
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
16%
Chemotherapy
16%
Disease
16%
Fibrinogen
100%
Lung Cancer
33%
Malignant Neoplasm
16%
Neoplasm
50%
Non Small Cell Lung Cancer
100%
Overall Survival
33%
Squamous Cell Carcinoma
16%
Transcription Factors
100%